Thai FDA — National Drug Information shortage bulletin (NDI-TH)
Thai FDA — National Drug Information shortage bulletin is the official source of medicine shortage information for Thailand (Asia Pacific). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- ndi.fda.moph.go.th
- Country
- Thailand
- Notices tracked by Mederti
- 151
- Last checked
- 2 Aug 2026
Latest notices from NDI-TH
- Chlorpheniramine/Hyoscyamine (1Ml) 10Mg/0.25Mg/Ml Injectable — active, medium, since 6 Feb 2023 (source)
- Lithium Carbonate — active, high, since 6 Feb 2023 (source)
- Sofosbuvir And Velpatasvir — active, medium, since 6 Feb 2023 (source)
- Vitamin D3 (50 — active, high, since 6 Feb 2023 (source)
- Cyclophosphamide — active, medium, since 6 Feb 2023 (source)
- Hydroxyprogesterone — active, medium, since 6 Feb 2023 (source)
- Salbutamol — active, medium, since 2 Feb 2023 (source)
- Chlorpheniramine/Hyoscyamine (1Ml) 10Mg/0.25Mg/Ml Injectable — active, medium, since 2 Feb 2023 (source)
- Bupropion — active, high, since 2 Feb 2023 (source)
- Ispaghula — active, medium, since 2 Feb 2023 (source)
- Aminophylline — active, medium, since 2 Feb 2023 (source)
- Quinine Sulfate — active, high, since 2 Feb 2023 (source)
- Albumin — active, high, since 2 Feb 2023 (source)
- Thioridazine — active, medium, since 2 Feb 2023 (source)
- Guaifenesin Usp — active, medium, since 2 Feb 2023 (source)
Every NDI-TH notice, searchable and alertable
Search Thailand's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by Thai FDA — National Drug Information shortage bulletin. All notices remain the property of their publisher and are linked to the original source.